Smooth Muscle Cells Asthma: Evidence of Expression by Airway Increased Expression of IL-33 in Severe

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-33 Mediates Inflammatory Responses in Human Airway Epithelial Cells and Microvascular Endothelial Cells.

  2009cited by this paper
• The airway vasculature: recent advances and clinical implications

  2009cited by this paper
• Targeting TNF-α: A novel therapeutic approach for asthma

  2008cited by this paper
• A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.

  2008cited by this paper
• Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket

  2008cited by this paper
• Differences in airway cytokine profile in severe asthma compared to moderate asthma.

  2008cited by this paper
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

  2007cited by this paper
• The role of epithelial injury and repair in the origins of asthma

  2007cited by this paper
• Evidence Based Selection of Housekeeping Genes

  2007cited by this paper
• IL-33: A Sheep in Wolf’s Clothing?

  2007cited by this paper
• Increased expression of ADAM33 and ADAM8 with disease progression in asthma.

  2007cited by this paper
• IL‐33 is a chemoattractant for human Th2 cells

  2007cited by this paper
• Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation*

  2007influential reference
• IL‐33 induces IL‐13 production by mouse mast cells independently of IgE‐FcεRI signals

  2007cited by this paper
• Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1

  2007cited by this paper
• Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.

  2007cited by this paper
• TNF α and IFN γ inversely modulate expression of the IL-17 E receptor in Airway Smooth Muscle Cells

  2006cited by this paper
• Evidence of a role of tumor necrosis factor alpha in refractory asthma.

  2006cited by this paper
• The Effects of a Monoclonal Antibody Directed against Tumor Necrosis Factor-α in Asthma

  2006cited by this paper
• Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma.

  2005cited by this paper
• An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor.

  2005cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005influential reference
• Niflumic acid and MSI-2216 reduce TNF-α–induced mucin expression in human airway mucosa

  2005cited by this paper
• Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells.

  2004cited by this paper
• CD38‐cyclic ADP‐ribose‐mediated Ca2+ signaling contributes to airway smooth muscle hyperresponsiveness

  2003influential reference
• 呼吸机相关性肺炎的非侵入性与侵入性检查 [英]／Ruiz M…／／Am J Respir Crit Care Med

  2002cited by this paper
• Mast-cell infiltration of airway smooth muscle in asthma.

  2002cited by this paper
• T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses

  2000cited by this paper
• Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle.

  1999cited by this paper
• Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses

  1999cited by this paper
• Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells.

  1999cited by this paper
• The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function

  1999cited by this paper
• Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids.

  1998cited by this paper
• Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway.

  1998cited by this paper
• T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.

  1998cited by this paper
• Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells.

  1998cited by this paper
• Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone

  1997cited by this paper
• Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids.

  1997cited by this paper
• Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis.

  1993cited by this paper
• Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

  1992cited by this paper
• TNFα mRNA expression in allergic inflammation

  1991cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper

• No citing papers are available for this paper.